Literature DB >> 1024826

Experimental examinations on the suitability of organoaminomethane-bis-phosphonic acids for bone-scintigraphy by means of Tc-99m in animals.

S Unterspann.   

Abstract

Phosphororganic compounds of the general formula R2N-CH (PO(OH)2)2 were examined for their Tc-99m-labelability and suitability for bone-scintigraphy. Compared to Tc-99-m-Sn-EHDP (Hydroxyethane-1,1-diphosphonic acid), four compounds showed a better concentration in the sceleton, while three compounds remained beneath comparative values.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1024826     DOI： 10.1007/BF00257962

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN： 0340-6997


  16 in total

1.  Enhanced detection of a skeletal lesion with delayed 99mTc-polyphosphate bone scanning.

Authors:  W D Kaplan; B L Holman; P A Liebow; M A Davis
Journal:  J Nucl Med       Date:  1974-01       Impact factor: 10.057

2.  A 99mTc-pyrophosphate kit: a convenient, economical, and high-quality skeletal-imaging agent.

Authors:  J P Huberty; R S Hattner; M R Powell
Journal:  J Nucl Med       Date:  1974-02       Impact factor: 10.057

3.  Positive 99mTc-polyphosphate scan in case of metastatic osteogenic sarcoma and hypertrophic pulmonary osteoarthropathy.

Authors:  A C Brower; C D Teates
Journal:  J Nucl Med       Date:  1974-01       Impact factor: 10.057

4.  Development of technetium-99m labeled 1-hydroxy-ethylidene-1,1-disodium phosphonate for skeletal imaging.

Authors:  R J Callahan; F P Castronovo
Journal:  Am J Hosp Pharm       Date:  1973-07

5.  Effects of radiation therapy on bone lesions as measured by 99m Tc-diphosphonate.

Authors:  F P Castronovo; M S Potsaid; H P Pendergrass
Journal:  J Nucl Med       Date:  1973-08       Impact factor: 10.057

6.  99m Tc-polyphosphate: histological localization in human femurs by autoradiography.

Authors:  R L Tilden; J Jackson; W F Enneking; F H DeLand; J T McVey
Journal:  J Nucl Med       Date:  1973-08       Impact factor: 10.057

7.  New bone scanning agent: 99m Tc-labeled 1-hydroxy-ethylidene-1, 1-disodium phosphonate.

Authors:  F P Castronovo; R J Callahan
Journal:  J Nucl Med       Date:  1972-11       Impact factor: 10.057

8.  99m Tc-EHDP: a potential radiopharmaceutical for skeletal imaging.

Authors:  G Subramanian; J G McAfee; R J Blair; A Mehter; T Connor
Journal:  J Nucl Med       Date:  1972-12       Impact factor: 10.057

9.  Technetium-99m-methylene diphosphonate--a superior agent for skeletal imaging: comparison with other technetium complexes.

Authors:  G Subramanian; J G McAfee; R J Blair; F A Kallfelz; F D Thomas
Journal:  J Nucl Med       Date:  1975-08       Impact factor: 10.057

10.  Method for the synthesis of 1-hydroxy-ethylidene-1, 1-disodium phosphonate (HEDSPA): a skeletal seeking radiopharmaceutical after labeling with 99mTc.

Authors:  F P Castronovo
Journal:  J Nucl Med       Date:  1974-02       Impact factor: 10.057
View more
  2 in total

1.  Technetium-1,2-dihydroxy-1,2-bis(dihydroxyphosphinyl)ethane (99mTc-DHPE). A promising new skeletal imaging agent.

Authors:  S C Archimandritis; A K Tsolis
Journal:  Eur J Nucl Med       Date:  1987

2.  Chemical structure and pharmacokinetics of 99mTc-labelled aminomethane diphosphonic acid derivatives.

Authors:  S Unterspann; W Finck
Journal:  Eur J Nucl Med       Date:  1981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.